Search research articles
Contact Us
Filters
Showing results (51-60 of 93) with videos related to
Page
of 10
Sort By:
Journal of Thoracic Disease
|
February 8, 2020
What is synchronous oligometastatic non-small cell lung cancer?
Chan-Kyung Jane Cho, Balamurugan A Vellayappan, Emma M Dunne, et al.
Journal of Medical Imaging and Radiation Sciences
|
May 5, 2019
Template-based Intensity-Modulated Radiation Therapy: A Cost-effective Intensity-Modulated Radiation Therapy Planning Procedure for Prostate Cancer
Fred Cao, Ramani Ramaseshan, Nancy Cooper, et al.
JTO Clinical and Research Reports
|
May 2, 2022
Comparison of 2-Weekly Versus 4-Weekly Durvalumab Consolidation for Locally Advanced NSCLC Treated With Chemoradiotherapy: A Brief Report
Marie-Hélène Denault, Shelley Kuang, Aria Shokoohi, et al.
Practical Radiation Oncology
|
September 20, 2024
Effect of Treatment Delivery Schedule for Patients With Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy: A Population-Based Analysis
John Paul Abrina, Sarah Baker, Ella Mae Cruz-Lim, et al.
American Journal of Clinical Oncology
|
February 8, 2006
Examining time intervals between diagnosis and treatment in the management of patients with limited stage small cell lung cancer
Eric Berthelet, Pauline T Truong, Mary Lesperance, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 31, 2003
Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy
Mitchell Liu, Tom Pickles, Alexander Agranovich, et al.
Frontiers in Oncology
|
June 14, 2023
Mathematical prediction with pretreatment growth rate of metastatic cancer on outcomes: implications for the characterization of oligometastatic disease
Yerim Shin, Jee Suk Chang, Yeseul Kim, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 2, 2017
Prospective analysis of patient reported symptoms and quality of life in patients with incurable lung cancer treated in a rapid access clinic
Shilo Lefresne, Robert Olson, Rosemary Cashman, et al.
Current Oncology (Toronto, Ont.)
|
August 25, 2023
Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression
Marie-Hélène Denault, Jamie Feng, Shelley Kuang, et al.
Radiation Oncology (London, England)
|
May 27, 2026
Efficacy and safety of metastasis-directed therapy for oligometastatic cancer: a systematic review and meta-analysis of randomized controlled trials
David Chen, Ealia Khoshkish, Jane Jomy, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 93) with videos related to
Sort By:
Page
of 10
Journal of Thoracic Disease
|
February 8, 2020
What is synchronous oligometastatic non-small cell lung cancer?
Chan-Kyung Jane Cho, Balamurugan A Vellayappan, Emma M Dunne, et al.
Journal of Medical Imaging and Radiation Sciences
|
May 5, 2019
Template-based Intensity-Modulated Radiation Therapy: A Cost-effective Intensity-Modulated Radiation Therapy Planning Procedure for Prostate Cancer
Fred Cao, Ramani Ramaseshan, Nancy Cooper, et al.
JTO Clinical and Research Reports
|
May 2, 2022
Comparison of 2-Weekly Versus 4-Weekly Durvalumab Consolidation for Locally Advanced NSCLC Treated With Chemoradiotherapy: A Brief Report
Marie-Hélène Denault, Shelley Kuang, Aria Shokoohi, et al.
Practical Radiation Oncology
|
September 20, 2024
Effect of Treatment Delivery Schedule for Patients With Early-Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy: A Population-Based Analysis
John Paul Abrina, Sarah Baker, Ella Mae Cruz-Lim, et al.
American Journal of Clinical Oncology
|
February 8, 2006
Examining time intervals between diagnosis and treatment in the management of patients with limited stage small cell lung cancer
Eric Berthelet, Pauline T Truong, Mary Lesperance, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 31, 2003
Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy
Mitchell Liu, Tom Pickles, Alexander Agranovich, et al.
Frontiers in Oncology
|
June 14, 2023
Mathematical prediction with pretreatment growth rate of metastatic cancer on outcomes: implications for the characterization of oligometastatic disease
Yerim Shin, Jee Suk Chang, Yeseul Kim, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 2, 2017
Prospective analysis of patient reported symptoms and quality of life in patients with incurable lung cancer treated in a rapid access clinic
Shilo Lefresne, Robert Olson, Rosemary Cashman, et al.
Current Oncology (Toronto, Ont.)
|
August 25, 2023
Beyond PACIFIC: Real-World Outcomes of Adjuvant Durvalumab According to Treatment Received and PD-L1 Expression
Marie-Hélène Denault, Jamie Feng, Shelley Kuang, et al.
Radiation Oncology (London, England)
|
May 27, 2026
Efficacy and safety of metastasis-directed therapy for oligometastatic cancer: a systematic review and meta-analysis of randomized controlled trials
David Chen, Ealia Khoshkish, Jane Jomy, et al.
Page
of 10